235 related articles for article (PubMed ID: 16638935)
1. Correction of a murine model of von Willebrand disease by gene transfer.
Pergolizzi RG; Jin G; Chan D; Pierre L; Bussel J; Ferris B; Leopold PL; Crystal RG
Blood; 2006 Aug; 108(3):862-9. PubMed ID: 16638935
[TBL] [Abstract][Full Text] [Related]
2. Restoration of plasma von Willebrand factor deficiency is sufficient to correct thrombus formation after gene therapy for severe von Willebrand disease.
De Meyer SF; Vandeputte N; Pareyn I; Petrus I; Lenting PJ; Chuah MK; VandenDriessche T; Deckmyn H; Vanhoorelbeke K
Arterioscler Thromb Vasc Biol; 2008 Sep; 28(9):1621-6. PubMed ID: 18556568
[TBL] [Abstract][Full Text] [Related]
3. High and long-term von Willebrand factor expression after Sleeping Beauty transposon-mediated gene therapy in a mouse model of severe von Willebrand disease.
Portier I; Vanhoorelbeke K; Verhenne S; Pareyn I; Vandeputte N; Deckmyn H; Goldenberg DS; Samal HB; Singh M; Ivics Z; Izsvák Z; De Meyer SF
J Thromb Haemost; 2018 Mar; 16(3):592-604. PubMed ID: 29288565
[TBL] [Abstract][Full Text] [Related]
4. Correction of bleeding symptoms in von Willebrand factor-deficient mice by liver-expressed von Willebrand factor mutants.
Marx I; Lenting PJ; Adler T; Pendu R; Christophe OD; Denis CV
Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):419-24. PubMed ID: 18187670
[TBL] [Abstract][Full Text] [Related]
5. Biochemistry and genetics of von Willebrand factor.
Sadler JE
Annu Rev Biochem; 1998; 67():395-424. PubMed ID: 9759493
[TBL] [Abstract][Full Text] [Related]
6. In vivo gene transfer strategies to achieve partial correction of von Willebrand disease.
Wang L; Rosenberg JB; De BP; Ferris B; Wang R; Rivella S; Kaminsky SM; Crystal RG
Hum Gene Ther; 2012 Jun; 23(6):576-88. PubMed ID: 22482515
[TBL] [Abstract][Full Text] [Related]
7. Analysis of von Willebrand factor mRNA from the lung of pigs with severe von Willebrand disease by using a human cDNA probe.
Wu QY; Bahnak BR; Coulombel L; Kerbiriou-Nabias D; Drouet L; Piétu G; Meulien P; Pavirani A; Caen JP; Meyer D
Blood; 1988 May; 71(5):1341-6. PubMed ID: 3258769
[TBL] [Abstract][Full Text] [Related]
8. Hemostasis in patients with severe von Willebrand disease improves after normal platelet transfusion and normalizes with further correction of the plasma defect.
Castillo R; Escolar G; Monteagudo J; Aznar-Salatti J; Reverter JC; Ordinas A
Transfusion; 1997 Aug; 37(8):785-90. PubMed ID: 9280321
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic correction of von Willebrand disease type 3 blood-derived endothelial cells with lentiviral vectors expressing von Willebrand factor.
De Meyer SF; Vanhoorelbeke K; Chuah MK; Pareyn I; Gillijns V; Hebbel RP; Collen D; Deckmyn H; VandenDriessche T
Blood; 2006 Jun; 107(12):4728-36. PubMed ID: 16478886
[TBL] [Abstract][Full Text] [Related]
10. Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment.
Castaman G; Federici AB; Rodeghiero F; Mannucci PM
Haematologica; 2003 Jan; 88(1):94-108. PubMed ID: 12551832
[TBL] [Abstract][Full Text] [Related]
11. Von Willebrand's disease: case report and review of literature.
Echahdi H; El Hasbaoui B; El Khorassani M; Agadr A; Khattab M
Pan Afr Med J; 2017; 27():147. PubMed ID: 28904675
[TBL] [Abstract][Full Text] [Related]
12. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
[TBL] [Abstract][Full Text] [Related]
13. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
[TBL] [Abstract][Full Text] [Related]
14. Bleeding prophylaxis for major surgery in patients with type 2 von Willebrand disease with an intermediate purity factor VIII-von Willebrand factor concentrate (Haemate-P).
Michiels JJ; Berneman ZN; van der Planken M; Schroyens W; Budde U; van Vliet HH
Blood Coagul Fibrinolysis; 2004 Jun; 15(4):323-30. PubMed ID: 15166918
[TBL] [Abstract][Full Text] [Related]
15. Mutation-specific hemostatic variability in mice expressing common type 2B von Willebrand disease substitutions.
Golder M; Pruss CM; Hegadorn C; Mewburn J; Laverty K; Sponagle K; Lillicrap D
Blood; 2010 Jun; 115(23):4862-9. PubMed ID: 20371742
[TBL] [Abstract][Full Text] [Related]
16. von Willebrand disease in the RIIIS/J mouse is caused by a defect outside of the von Willebrand factor gene.
Nichols WC; Cooney KA; Mohlke KL; Ballew JD; Yang A; Bruck ME; Reddington M; Novak EK; Swank RT; Ginsburg D
Blood; 1994 Jun; 83(11):3225-31. PubMed ID: 8193357
[TBL] [Abstract][Full Text] [Related]
17. Molecular genetics of von Willebrand disease.
Mazurier C; Ribba AS; Gaucher C; Meyer D
Ann Genet; 1998; 41(1):34-43. PubMed ID: 9599650
[TBL] [Abstract][Full Text] [Related]
18. Type 2M von Willebrand disease: F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin- but not botrocetin-mediated binding of von Willebrand factor to platelets.
Hillery CA; Mancuso DJ; Evan Sadler J; Ponder JW; Jozwiak MA; Christopherson PA; Cox Gill J; Paul Scott J; Montgomery RR
Blood; 1998 Mar; 91(5):1572-81. PubMed ID: 9473222
[TBL] [Abstract][Full Text] [Related]
19. A new mutation, S1285F, within the A1 loop of von Willebrand factor induces a conformational change in A1 loop with abnormal binding to platelet GPIb and botrocetin causing type 2M von Willebrand disease.
Stepanian A; Ribba AS; Lavergne JM; Fressinaud E; Juhan-Vague I; Mazurier C; Girma JP; Meyer D
Br J Haematol; 2003 Feb; 120(4):643-51. PubMed ID: 12588351
[TBL] [Abstract][Full Text] [Related]
20. Guidelines for the diagnosis and management of von Willebrand disease in Italy.
Federici AB; Castaman G; Mannucci PM;
Haemophilia; 2002 Sep; 8(5):607-21. PubMed ID: 12199668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
